Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04899947 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Child and Adolescent Registry for Participants With Narcolepsy

StatusUnknown
PhaseNot specified
Started2020-10-10
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 15, 2024 (before its estimated October 1, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
2024-08-13
Study Status v20
Trial statusRecruiting→Unknown
2024-05-14
Study Status v19
Re-verified, no change to tracked fields
2024-03-28
Study Status v18
Primary completion date2024-10→2024-10-01
Completion date2024-10→2024-10-01
2023-05-16
7 amendments v11-v17
7 re-verifications since 2022-10-21, no change to tracked fields
Show 10 earlier versions
2022-09-27
Study Status, Study Description, References v10
2022-08-15
5 amendments v5-v9
5 re-verifications since 2022-03-07, no change to tracked fields
2022-01-06
Study Status, Contacts/Locations v4
Study sites24→25
2021-09-10
Study Status, Contacts/Locations v3
Study sitesdetails revised at 1 of 24 sites
2021-07-23
Study Status, Contacts/Locations v2
Study sites23→24
2021-07-09
Study Status, Contacts/Locations v1
Study sites22→23
2021-05-21
Original filing
CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed. The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.
Trial Details
NCT Number NCT04899947
Lead Sponsor Jazz Pharmaceuticals
Conditions Narcolepsy
Enrollment 500 participants
Start Date 2020-10-10
Primary Completion 2024-10-01 (estimated)
Study Completion 2024-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-15